Track Instil Bio, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Instil Bio, Inc. TIL Open Instil Bio, Inc. in new tab

8.13 USD
EPS
-10.70
P/B
0.48
ROE
-50.39
Beta
1.95
Key Metrics
Earnings dateAug. 7, 2026
EPS-10.70
Book Value16.79
Price to Book0.48
Debt/Equity74.81
% Insiders6.294%
Estimates
Forward P/E-0.55
Forward EPS-14.64

DCF Valuation

Tweak assumptions to recompute fair value for Instil Bio, Inc. (TIL)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Instil Bio, Inc. Analysis (TIL)

United States Health Care Stock

Is Instil Bio, Inc. a good investment? Instil Bio, Inc. (TIL) is currently trading at 8.13 USD.

Earnings Schedule: Instil Bio, Inc. is expected to release its next earnings report on Aug. 7, 2026. The market consensus estimate for Forward EPS is -14.64.

Investor FAQ

Does Instil Bio, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Instil Bio, Inc.?

Instil Bio, Inc. is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Aug. 7, 2026. The company currently has a trailing EPS of -10.70.

Company Profile

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion